NewsBenzinga리어링크 파트너스, 팔벨라 테라퓨틱스에 대한 커버리지 개시···‘시장수익률 상회’ 의견 및 목표주가 228달러 제시 리어링크 파트너스, 팔벨라 테라퓨틱스에 대한 커버리지 개시···‘시장수익률 상회’ 의견 및 목표주가 228달러 제시 Benzinga 2026.11.16 13:30 (GMT+0) Open on Benzinga Other news Morgan Stanley Maintains Equal-Weight on W.W. Grainger, Raises Price Target to $1590 SpaceX's IPO Playbook Could Give Anthropic A $19B Buying Cushion—But There's A Catch What Is Going on With CoreWeave Stock on Monday? Morgan Stanley Maintains Underweight on Virgin Galactic Holdings, Lowers Price Target to $1.75 Occidental Petroleum Analyst Turns Bearish Due To Limited Volume Upside If You Invested $1000 In Monster Beverage Stock 5 Years Ago, You Would Have This Much Today